doi:

DOI: 10.3724/SP.J.1264.2011.00001

Chinese Journal of Multiple Organ Diseases in the Elderly (中华老年多器官疾病杂志) 2011/10:4 PP.289-292

Strategy for diagnosis and treatment of diabetes in the elderly—— from guideline to practice


Abstract:
The elderly are more likely to develop diabetes mellitus. More than half of the diabetic patients are elderly individuals. The outcome of these patients differs greatly due to the complex of the condition, the variety of complicated diseases, and multiplicity of the influencing factors. So, it is very important to evaluate their accommodation ability, the function of the major organs, and the level of self-management to establish the individualized treatment strategy and blood glucose control target for different patients. The modification of life style is the basic treatment option for metabolic disorder. Early diagnosis and treatment are decisive to the patients¢ prognosis. Metformin, glycosidase inhibitors and dipeptidyl aminopeptidase inhibitors are the first-line oral antidiabetic drugs. The timely use of insulin is beneficial for the control of blood glucose. The comprehensive control of multiple cardio-vascular risk factors, especially the blood pressure and body weight control, should be emphasized.

Key words:elderly,diabetes mellitus,diagnosis,treatment

ReleaseDate:2014-07-21 15:56:12



[1] Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12): 1090-1101.

[2] 李立柱, 方福生, 田 慧, 等. 中老年干部人群3年体检中糖代谢异常率增长情况及影响因素分析[J]. 解放军医学杂志, 2011, 36(5): 505-507.

[3] 国家“九五”攻关计划糖尿病研究协作组. 中国12个地区中老年人糖尿病患病率调查[J]. 中华内分泌代谢杂志, 2002; 18(4): 280-284.

[4] 俞银燕, 田 慧, 方福生, 等. 门诊2型糖尿病合并代谢综合征患者的综合控制达标情况及影响因素调查[J]. 中华保健医学杂志, 2010, 12(6): 427-430.

[5] 李晨曦, 田 慧, 李春霖, 等. 综合管理对老年2型糖尿病患者血糖控制达标的促进作用[J]. 中华保健医学杂志, 2011, 13(2): 113-116.

[6] 迟家敏, 吴 青, 秦明照, 等. 北京地区2077例2型糖尿病患者治疗达标调查[J]. 北京医学, 2008, 30(8): 513-515.

[7] 王伟文. 影响糖尿病患者药物治疗依从性相关因素临床分析[J]. 上海医药, 2009, 30(3): 133-134.

[8] 中华医学会内分泌学会. 中国成人2型糖尿病HbA1c控制目标的专家共识[J]. 中华内分泌代谢杂志, 2011, 27(5): 371-374.

[9] Chehade JM. Drug therapy: Current and emerging agents[A]//Sinclair AJ, Finucane P. Diabetes in old age[M]. 2nd ed. John Wiley & Sons: Chichester, 2001: 202.

[10] 田 慧, 李春霖, 杨 光. 二甲双胍在老年2型糖尿病患者应用的安全性评估[J]. 中华内科杂志, 2008, 47(11): 914- 918.

[11] De Cunto A, Barbi E, Minen F, et al. Safety and efficacy of high-dose acarbose treatment for dumping syndrome[J]. J Pediatr Gastroenterol Nutr. 2011, 53(1): 113-114.

[12] Barzilai N, Guo H, Mahoney EM, et al. Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo- controlled trial[J]. Curr Med Res Opin. 2011, 27(5): 1049-1058.

[13] Reasner C, Olansky L, Seck TL, et al. The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus[J]. Diabetes Obes Metab, 2011, 13(7): 644-652.

[14] Hsia SH, Navar MD, Duran P, et al. Sitagliptin compared to thiazolidinediones as a third-line oral anti-hyperglycemic agent in type 2 diabetes mellitus[J]. Endocr Pract. 2011, 6: 1-21.

[15] 田 慧. 老年糖尿病胰岛素治疗模式及安全性评估[J]. 实用内科杂志, 2008, 28(4): 246-249.

PDF